Lateral flow assays (LFAs), such as the COVID-19 rapid test ... To increase LFA sensitivity and testing capacity, researchers adapted LFA technology so they can detect RNA or DNA instead of proteins.

This protein can easily be programmed to find and bind to almost any desired target sequence, simply by giving it a piece of RNA to guide it in its search. When the CRISPR Cas9 protein is added to ...

Enter the anti-CRISPR protein AcrVIB1, a promising inhibitor whose exact function has remained a mystery—until now. A research team from the Helmholtz Institute for RNA-based Infection Research ...